EKTAF (Elekta AB) Short Percentage of Float


EKTAF Elekta AB EKTAF
77 GF Score
Price $5.04
GF Value $6.07
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Elekta AB Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


EKTAF vs ABT, SYK, MDT: Short Percentage of Float Comparison

For the Medical Devices subindustry, Elekta AB's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elekta AB Short Percentage of Float vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Elekta AB's Short Percentage of Float falls into.


EKTAF
77GF Score
Elekta AB EKTAF
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Elekta AB (EKTAF) Overvalued in 2026?

Based on GuruFocus' analysis, Elekta AB stock appears to be undervalued. The current stock price of $5.04 is trading 17% below its estimated GF Value™ of $6.07. GuruFocus considers Elekta AB to be Modestly Undervalued.

Key valuation signals for EKTAF:

  • Short Percentage of Float:
  • GF Value™: $6.07 vs. price of $5.04 (17% below fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the EKTAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Elekta AB Business Description

Address Hagaplan 4, Box 7593, Stockholm, SWE, 11368
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,300 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 29%; Europe, the Middle East, and Africa accounting for 37%; and the Asia-Pacific contributing the remainder.
77GF Score

Get the complete analysis for EKTAF

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.04
Price
$6.07
GF Value